Gül Başaran

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.

Perran Fulden Yumuk, Taflan Salepçi, Mehmet Aliustaoğlu et al. · PubMed · 2006 · 98 citations · Full text

Medicine, Oncology, Pathology +11

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

The association between individual attachment patterns, the perceived social support, and the psychological well‐being of Turkish informal caregivers

M. Kemal Kuşçu, Uzay Dural, Yeşim Yaşa et al. · Psycho-Oncology · 2009 · 68 citations · Full text

Nursing, Oncology, Behavioral Health +16

Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer

Umut Kefeli, Faysal Dane, Perran Fulden Yumuk et al. · European Journal of Cancer Care · 2009 · 49 citations

Pharmacy, Oncology, Pharmacotherapy +17